Share Price and Basic Stock Data
Last Updated: December 24, 2025, 2:56 pm
| PEG Ratio | 0.00 |
|---|
Analyst Insight & Comprehensive Analysis
AI Stock Ranker – Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
CHD Chemicals Ltd operates within the trading and distribution sector, focusing on the chemical industry. The company has witnessed significant fluctuations in its revenue over recent years. For instance, sales fell sharply from ₹75.47 Cr in FY 2019 to ₹19.06 Cr in FY 2023, reflecting a downward trend that has raised eyebrows among investors. The quarterly figures further illustrate this volatility; for example, the revenue for the quarter ending March 2023 was just ₹3.27 Cr, a stark contrast to ₹6.59 Cr reported in the same quarter the previous year. Such fluctuations may point to market challenges or operational inefficiencies impacting its ability to maintain steady sales. The latest trailing twelve months (TTM) revenue stands at ₹6.64 Cr, indicating a continued struggle to regain its former levels. This trend raises questions about the company’s market positioning and competitive strategy in a challenging economic landscape.
Profitability and Efficiency Metrics
Profitability metrics for CHD Chemicals tell a concerning story. The operating profit margin (OPM) has shown variability, standing at just 2.78% recently, which is relatively low compared to industry standards. The company reported a net profit of ₹0.08 Cr in FY 2023, but this is a significant drop from ₹0.51 Cr in FY 2022. This decline in profitability aligns with rising expenses, which have not been effectively controlled, as seen from the ₹18.43 Cr in total expenses for FY 2023. Additionally, the interest coverage ratio (ICR) has dipped to 0.94x, indicating that the company barely covers its interest obligations, which could lead to financial strain. The cash conversion cycle (CCC) of 960.81 days is alarmingly high, suggesting that CHD Chemicals is struggling with inventory management and receivables, further complicating its operational efficiency.
Balance Sheet Strength and Financial Ratios
The balance sheet of CHD Chemicals presents a mixed picture. As of FY 2025, the company reported total borrowings of ₹5.97 Cr against total reserves of ₹2.80 Cr, indicating a reliance on debt financing to sustain operations. The debt-to-equity ratio stands at 0.51x, which is manageable but raises concerns about financial leverage, especially considering the declining profitability. The current ratio of 6.51x appears strong, suggesting that the company has ample short-term assets to cover its liabilities. However, the return on equity (ROE) is a meager 1.51%, reflecting poor shareholder returns, which may deter potential investors. Furthermore, the price-to-book value (P/BV) ratio of 0.44x indicates the stock is trading below its book value, which could attract value investors, but it also underscores market skepticism regarding future growth prospects.
Shareholding Pattern and Investor Confidence
In terms of shareholding, CHD Chemicals has a relatively stable structure, with promoters holding 27.49% and the public accounting for 72.32% of the total shares. This distribution suggests a broad base of retail investors, which could indicate a level of public confidence in the company. However, the lack of Foreign Institutional Investors (FIIs) and a minimal presence of Domestic Institutional Investors (DIIs) at 0.20% may signal hesitance from larger, more influential investors. The number of shareholders has decreased from 9,075 in December 2022 to 8,303 in March 2025, which raises concerns about investor sentiment and could reflect a lack of confidence in the company’s growth trajectory. This drop in shareholder numbers, combined with the stagnant share price of ₹5.51, could deter new investments, highlighting a critical area for management to address in order to regain market confidence.
Outlook, Risks, and Final Insight
Looking ahead, CHD Chemicals faces an uphill battle to regain its footing in a competitive market. The risks are evident: declining revenues, high operational costs, and a concerning cash conversion cycle suggest that the company needs to implement robust operational strategies to improve profitability. Investors should be cautious, as the poor financial metrics could lead to further declines in market confidence. On the flip side, the low P/BV ratio may offer a potential entry point for value investors if the company can successfully execute a turnaround. However, without a clear strategy to address its operational inefficiencies and improve its financial health, the outlook remains uncertain. Investors should closely monitor quarterly results and any strategic announcements that might signal a shift in the company’s fortunes. The combination of a stable shareholding structure and the company’s current challenges presents both risks and opportunities that require careful consideration.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Minal Industries Ltd | 59.7 Cr. | 3.11 | 5.59/2.85 | 39.8 | 2.78 | 0.00 % | 5.97 % | 2.83 % | 2.00 |
| Mitshi India Ltd | 13.1 Cr. | 14.9 | 18.6/13.0 | 3.09 | 0.00 % | 0.36 % | 0.37 % | 10.0 | |
| Modella Woollens Ltd | 6.55 Cr. | 72.0 | 74.8/52.5 | 4.95 | 0.00 % | % | % | 10.0 | |
| MRC Agrotech Ltd | 100 Cr. | 48.9 | 54.5/10.2 | 111 | 15.1 | 0.00 % | 5.89 % | 4.46 % | 10.0 |
| MRP Agro Ltd | 104 Cr. | 94.0 | 174/84.4 | 14.8 | 30.6 | 0.00 % | 39.2 % | 30.3 % | 10.0 |
| Industry Average | 9,462.83 Cr | 160.61 | 86.71 | 122.23 | 0.41% | 15.37% | 8.86% | 7.71 |
Quarterly Result
| Metric | Mar 2022 | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 6.59 | 4.99 | 4.42 | 6.39 | 3.27 | 3.45 | 4.65 | 3.84 | 4.30 | 1.52 | 2.06 | 1.87 | 1.44 |
| Expenses | 6.22 | 4.78 | 4.29 | 6.48 | 2.89 | 3.27 | 4.30 | 3.70 | 4.16 | 1.67 | 1.96 | 1.82 | 1.40 |
| Operating Profit | 0.37 | 0.21 | 0.13 | -0.09 | 0.38 | 0.18 | 0.35 | 0.14 | 0.14 | -0.15 | 0.10 | 0.05 | 0.04 |
| OPM % | 5.61% | 4.21% | 2.94% | -1.41% | 11.62% | 5.22% | 7.53% | 3.65% | 3.26% | -9.87% | 4.85% | 2.67% | 2.78% |
| Other Income | 0.01 | 0.01 | 0.03 | 0.01 | 0.01 | 0.01 | 0.01 | 0.03 | -0.01 | 0.01 | 0.01 | 0.01 | 0.18 |
| Interest | 0.21 | 0.09 | 0.11 | 0.08 | 0.10 | 0.07 | 0.08 | 0.06 | 0.06 | 0.06 | 0.04 | 0.05 | 0.10 |
| Depreciation | 0.04 | 0.05 | 0.05 | 0.05 | 0.06 | 0.06 | 0.08 | 0.05 | 0.04 | 0.06 | 0.06 | 0.03 | 0.04 |
| Profit before tax | 0.13 | 0.08 | 0.00 | -0.21 | 0.23 | 0.06 | 0.20 | 0.06 | 0.03 | -0.26 | 0.01 | -0.02 | 0.08 |
| Tax % | 30.77% | 25.00% | -57.14% | 17.39% | 33.33% | 20.00% | 33.33% | 33.33% | 61.54% | -1,700.00% | 0.00% | 12.50% | |
| Net Profit | 0.09 | 0.05 | 0.00 | -0.09 | 0.19 | 0.05 | 0.15 | 0.04 | 0.02 | -0.42 | 0.18 | -0.02 | 0.07 |
| EPS in Rs | 0.09 | 0.05 | 0.00 | -0.09 | 0.19 | 0.05 | 0.15 | 0.04 | 0.02 | -0.42 | 0.18 | -0.02 | 0.07 |
Last Updated: May 31, 2025, 6:32 am
Below is a detailed analysis of the quarterly data for CHD Chemicals Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:
- For Sales, as of Mar 2025, the value is 1.44 Cr.. The value appears to be declining and may need further review. It has decreased from 1.87 Cr. (Dec 2024) to 1.44 Cr., marking a decrease of 0.43 Cr..
- For Expenses, as of Mar 2025, the value is 1.40 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 1.82 Cr. (Dec 2024) to 1.40 Cr., marking a decrease of 0.42 Cr..
- For Operating Profit, as of Mar 2025, the value is 0.04 Cr.. The value appears to be declining and may need further review. It has decreased from 0.05 Cr. (Dec 2024) to 0.04 Cr., marking a decrease of 0.01 Cr..
- For OPM %, as of Mar 2025, the value is 2.78%. The value appears strong and on an upward trend. It has increased from 2.67% (Dec 2024) to 2.78%, marking an increase of 0.11%.
- For Other Income, as of Mar 2025, the value is 0.18 Cr.. The value appears strong and on an upward trend. It has increased from 0.01 Cr. (Dec 2024) to 0.18 Cr., marking an increase of 0.17 Cr..
- For Interest, as of Mar 2025, the value is 0.10 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 0.05 Cr. (Dec 2024) to 0.10 Cr., marking an increase of 0.05 Cr..
- For Depreciation, as of Mar 2025, the value is 0.04 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 0.03 Cr. (Dec 2024) to 0.04 Cr., marking an increase of 0.01 Cr..
- For Profit before tax, as of Mar 2025, the value is 0.08 Cr.. The value appears strong and on an upward trend. It has increased from -0.02 Cr. (Dec 2024) to 0.08 Cr., marking an increase of 0.10 Cr..
- For Tax %, as of Mar 2025, the value is 12.50%. The value appears to be increasing, which may not be favorable. It has increased from 0.00% (Dec 2024) to 12.50%, marking an increase of 12.50%.
- For Net Profit, as of Mar 2025, the value is 0.07 Cr.. The value appears strong and on an upward trend. It has increased from -0.02 Cr. (Dec 2024) to 0.07 Cr., marking an increase of 0.09 Cr..
- For EPS in Rs, as of Mar 2025, the value is 0.07. The value appears strong and on an upward trend. It has increased from -0.02 (Dec 2024) to 0.07, marking an increase of 0.09.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: December 15, 2025, 3:59 am
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 14.39 | 44.25 | 40.35 | 42.84 | 34.35 | 75.47 | 85.82 | 68.67 | 31.28 | 19.06 | 16.21 | 6.88 | 5.71 |
| Expenses | 14.19 | 43.62 | 39.69 | 41.83 | 33.83 | 73.98 | 84.49 | 67.99 | 30.45 | 18.43 | 15.40 | 6.85 | 5.78 |
| Operating Profit | 0.20 | 0.63 | 0.66 | 1.01 | 0.52 | 1.49 | 1.33 | 0.68 | 0.83 | 0.63 | 0.81 | 0.03 | -0.07 |
| OPM % | 1.39% | 1.42% | 1.64% | 2.36% | 1.51% | 1.97% | 1.55% | 0.99% | 2.65% | 3.31% | 5.00% | 0.44% | -1.23% |
| Other Income | 0.00 | 0.04 | 0.10 | 0.05 | 0.74 | 0.04 | 0.03 | 0.03 | 0.03 | 0.05 | 0.04 | 0.21 | 0.30 |
| Interest | 0.06 | 0.27 | 0.25 | 0.37 | 0.35 | 0.35 | 0.36 | 0.38 | 0.47 | 0.37 | 0.28 | 0.25 | 0.21 |
| Depreciation | 0.02 | 0.09 | 0.13 | 0.16 | 0.22 | 0.29 | 0.28 | 0.23 | 0.16 | 0.22 | 0.22 | 0.19 | 0.17 |
| Profit before tax | 0.12 | 0.31 | 0.38 | 0.53 | 0.69 | 0.89 | 0.72 | 0.10 | 0.23 | 0.09 | 0.35 | -0.20 | -0.15 |
| Tax % | 25.00% | 29.03% | 28.95% | 33.96% | 26.09% | 25.84% | 27.78% | 50.00% | -121.74% | 22.22% | 25.71% | 0.00% | |
| Net Profit | 0.09 | 0.21 | 0.27 | 0.35 | 0.52 | 0.66 | 0.53 | 0.06 | 0.51 | 0.07 | 0.26 | -0.20 | -0.15 |
| EPS in Rs | 0.66 | 0.62 | 0.52 | 0.54 | 0.59 | 0.65 | 0.52 | 0.06 | 0.50 | 0.07 | 0.26 | -0.20 | -0.15 |
| Dividend Payout % | 0.00% | 0.00% | 0.00% | 18.43% | 0.00% | 0.00% | 0.00% | 252.75% | 0.00% | 0.00% | 0.00% | 0.00% |
YoY Net Profit Growth
| Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | 133.33% | 28.57% | 29.63% | 48.57% | 26.92% | -19.70% | -88.68% | 750.00% | -86.27% | 271.43% | -176.92% |
| Change in YoY Net Profit Growth (%) | 0.00% | -104.76% | 1.06% | 18.94% | -21.65% | -46.62% | -68.98% | 838.68% | -836.27% | 357.70% | -448.35% |
CHD Chemicals Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | -17% |
| 5 Years: | -40% |
| 3 Years: | -40% |
| TTM: | -54% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | 138% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | -34% |
| 3 Years: | -9% |
| 1 Year: | -5% |
| Return on Equity | |
|---|---|
| 10 Years: | 3% |
| 5 Years: | 1% |
| 3 Years: | 0% |
| Last Year: | -2% |
Last Updated: September 5, 2025, 2:55 pm
Balance Sheet
Last Updated: December 4, 2025, 2:37 am
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 1.36 | 3.41 | 5.21 | 6.45 | 8.86 | 10.11 | 10.11 | 10.11 | 10.11 | 10.11 | 10.11 | 10.11 | 10.11 |
| Reserves | 0.09 | 0.39 | 0.84 | 2.10 | 1.92 | 2.27 | 2.80 | 2.70 | 3.23 | 2.95 | 3.21 | 3.01 | 2.80 |
| Borrowings | 0.86 | 1.92 | 2.08 | 2.65 | 1.01 | 4.06 | 1.87 | 6.22 | 19.74 | 9.10 | 6.61 | 6.72 | 5.97 |
| Other Liabilities | 11.87 | 13.99 | 16.63 | 11.90 | 11.21 | 19.53 | 28.99 | 23.96 | 7.28 | 4.42 | 3.15 | 1.41 | 1.14 |
| Total Liabilities | 14.18 | 19.71 | 24.76 | 23.10 | 23.00 | 35.97 | 43.77 | 42.99 | 40.36 | 26.58 | 23.08 | 21.25 | 20.02 |
| Fixed Assets | 0.58 | 0.51 | 0.32 | 0.49 | 1.42 | 1.22 | 0.93 | 0.75 | 1.06 | 0.90 | 0.69 | 0.51 | 0.68 |
| CWIP | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Assets | 13.60 | 19.20 | 24.44 | 22.61 | 21.58 | 34.75 | 42.84 | 42.24 | 39.30 | 25.68 | 22.39 | 20.74 | 19.34 |
| Total Assets | 14.18 | 19.71 | 24.76 | 23.10 | 23.00 | 35.97 | 43.77 | 42.99 | 40.36 | 26.58 | 23.08 | 21.25 | 20.02 |
Below is a detailed analysis of the balance sheet data for CHD Chemicals Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2025, the value is 10.11 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 10.11 Cr..
- For Reserves, as of Sep 2025, the value is 2.80 Cr.. The value appears to be declining and may need further review. It has decreased from 3.01 Cr. (Mar 2025) to 2.80 Cr., marking a decrease of 0.21 Cr..
- For Borrowings, as of Sep 2025, the value is 5.97 Cr.. The value appears to be improving (decreasing). However, Borrowings exceed Reserves, which may signal higher financial risk. It has decreased from 6.72 Cr. (Mar 2025) to 5.97 Cr., marking a decrease of 0.75 Cr..
- For Other Liabilities, as of Sep 2025, the value is 1.14 Cr.. The value appears to be improving (decreasing). It has decreased from 1.41 Cr. (Mar 2025) to 1.14 Cr., marking a decrease of 0.27 Cr..
- For Total Liabilities, as of Sep 2025, the value is 20.02 Cr.. The value appears to be improving (decreasing). It has decreased from 21.25 Cr. (Mar 2025) to 20.02 Cr., marking a decrease of 1.23 Cr..
- For Fixed Assets, as of Sep 2025, the value is 0.68 Cr.. The value appears strong and on an upward trend. It has increased from 0.51 Cr. (Mar 2025) to 0.68 Cr., marking an increase of 0.17 Cr..
- For CWIP, as of Sep 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
- For Investments, as of Sep 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
- For Other Assets, as of Sep 2025, the value is 19.34 Cr.. The value appears to be declining and may need further review. It has decreased from 20.74 Cr. (Mar 2025) to 19.34 Cr., marking a decrease of 1.40 Cr..
- For Total Assets, as of Sep 2025, the value is 20.02 Cr.. The value appears to be declining and may need further review. It has decreased from 21.25 Cr. (Mar 2025) to 20.02 Cr., marking a decrease of 1.23 Cr..
However, the Borrowings (5.97 Cr.) are higher than the Reserves (2.80 Cr.), which may signal higher financial risk.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow - No data available for this post.
Free Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | -0.66 | -1.29 | -1.42 | -1.64 | -0.49 | -2.57 | -0.54 | -5.54 | -18.91 | -8.47 | -5.80 | -6.69 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 286.12 | 128.02 | 162.28 | 154.64 | 188.72 | 140.16 | 155.75 | 184.81 | 372.23 | 358.11 | 386.84 | 816.48 |
| Inventory Days | 33.48 | 22.77 | 25.04 | 28.87 | 18.61 | 22.73 | 19.96 | 32.82 | 70.87 | 119.11 | 105.47 | 220.07 |
| Days Payable | 317.64 | 120.27 | 141.67 | 102.75 | 103.89 | 93.82 | 124.20 | 128.55 | 78.93 | 88.04 | 70.48 | 75.74 |
| Cash Conversion Cycle | 1.95 | 30.53 | 45.66 | 80.76 | 103.43 | 69.07 | 51.51 | 89.08 | 364.17 | 389.18 | 421.83 | 960.81 |
| Working Capital Days | 18.77 | 22.11 | 19.09 | 61.86 | 105.09 | 56.88 | 52.99 | 75.05 | 322.29 | 339.15 | 378.51 | 901.36 |
| ROCE % | 14.45% | 8.38% | 9.31% | 9.05% | 8.78% | 7.05% | 2.84% | 2.69% | 1.67% | 2.99% | 0.25% |
This stock is not held by any mutual fund.
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Basic EPS (Rs.) | -0.19 | 0.26 | 0.06 | 0.50 | 0.05 |
| Diluted EPS (Rs.) | -0.19 | 0.26 | 0.06 | 0.50 | 0.05 |
| Cash EPS (Rs.) | -0.01 | 0.47 | 0.28 | 0.66 | 0.28 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 12.98 | 13.17 | 12.92 | 13.19 | 12.67 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 12.98 | 13.17 | 12.92 | 13.19 | 12.67 |
| Dividend / Share (Rs.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.15 |
| Revenue From Operations / Share (Rs.) | 6.81 | 16.06 | 18.87 | 31.20 | 68.45 |
| PBDIT / Share (Rs.) | 0.23 | 0.83 | 0.67 | 0.84 | 0.70 |
| PBIT / Share (Rs.) | 0.04 | 0.61 | 0.45 | 0.69 | 0.48 |
| PBT / Share (Rs.) | -0.19 | 0.34 | 0.08 | 0.22 | 0.10 |
| Net Profit / Share (Rs.) | -0.19 | 0.25 | 0.06 | 0.50 | 0.05 |
| PBDIT Margin (%) | 3.40 | 5.23 | 3.56 | 2.71 | 1.03 |
| PBIT Margin (%) | 0.66 | 3.85 | 2.41 | 2.21 | 0.70 |
| PBT Margin (%) | -2.91 | 2.13 | 0.45 | 0.73 | 0.15 |
| Net Profit Margin (%) | -2.85 | 1.59 | 0.34 | 1.61 | 0.08 |
| Return on Networth / Equity (%) | -1.49 | 1.93 | 0.50 | 3.82 | 0.43 |
| Return on Capital Employeed (%) | 0.25 | 3.45 | 2.39 | 2.38 | 3.13 |
| Return On Assets (%) | -0.92 | 1.11 | 0.24 | 1.27 | 0.12 |
| Long Term Debt / Equity (X) | 0.37 | 0.35 | 0.47 | 1.22 | 0.21 |
| Total Debt / Equity (X) | 0.51 | 0.48 | 0.67 | 1.46 | 0.47 |
| Asset Turnover Ratio (%) | 0.31 | 0.65 | 0.57 | 0.76 | 1.59 |
| Current Ratio (X) | 6.51 | 4.48 | 3.49 | 3.62 | 1.54 |
| Quick Ratio (X) | 5.35 | 3.64 | 2.71 | 3.09 | 1.32 |
| Dividend Payout Ratio (NP) (%) | 0.00 | 0.00 | 0.00 | 0.00 | 270.85 |
| Dividend Payout Ratio (CP) (%) | 0.00 | 0.00 | 0.00 | 0.00 | 52.75 |
| Earning Retention Ratio (%) | 0.00 | 0.00 | 0.00 | 0.00 | -170.85 |
| Cash Earning Retention Ratio (%) | 0.00 | 0.00 | 0.00 | 0.00 | 47.25 |
| Interest Coverage Ratio (X) | 0.94 | 3.05 | 1.82 | 1.84 | 1.88 |
| Interest Coverage Ratio (Post Tax) (X) | 0.20 | 1.93 | 1.17 | 2.09 | 1.15 |
| Enterprise Value (Cr.) | 12.03 | 12.28 | 12.86 | 26.84 | 22.56 |
| EV / Net Operating Revenue (X) | 1.75 | 0.75 | 0.67 | 0.85 | 0.32 |
| EV / EBITDA (X) | 51.31 | 14.46 | 18.91 | 31.31 | 31.54 |
| MarketCap / Net Operating Revenue (X) | 0.84 | 0.39 | 0.24 | 0.25 | 0.24 |
| Retention Ratios (%) | 0.00 | 0.00 | 0.00 | 0.00 | -170.85 |
| Price / BV (X) | 0.44 | 0.47 | 0.35 | 0.59 | 1.33 |
| Price / Net Operating Revenue (X) | 0.84 | 0.39 | 0.24 | 0.25 | 0.24 |
| EarningsYield | -0.03 | 0.04 | 0.01 | 0.06 | 0.00 |
After reviewing the key financial ratios for CHD Chemicals Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
- For Basic EPS (Rs.), as of Mar 25, the value is -0.19. This value is below the healthy minimum of 5. It has decreased from 0.26 (Mar 24) to -0.19, marking a decrease of 0.45.
- For Diluted EPS (Rs.), as of Mar 25, the value is -0.19. This value is below the healthy minimum of 5. It has decreased from 0.26 (Mar 24) to -0.19, marking a decrease of 0.45.
- For Cash EPS (Rs.), as of Mar 25, the value is -0.01. This value is below the healthy minimum of 3. It has decreased from 0.47 (Mar 24) to -0.01, marking a decrease of 0.48.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 12.98. It has decreased from 13.17 (Mar 24) to 12.98, marking a decrease of 0.19.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 12.98. It has decreased from 13.17 (Mar 24) to 12.98, marking a decrease of 0.19.
- For Dividend / Share (Rs.), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 1. There is no change compared to the previous period (Mar 24) which recorded 0.00.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 6.81. It has decreased from 16.06 (Mar 24) to 6.81, marking a decrease of 9.25.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 0.23. This value is below the healthy minimum of 2. It has decreased from 0.83 (Mar 24) to 0.23, marking a decrease of 0.60.
- For PBIT / Share (Rs.), as of Mar 25, the value is 0.04. This value is within the healthy range. It has decreased from 0.61 (Mar 24) to 0.04, marking a decrease of 0.57.
- For PBT / Share (Rs.), as of Mar 25, the value is -0.19. This value is below the healthy minimum of 0. It has decreased from 0.34 (Mar 24) to -0.19, marking a decrease of 0.53.
- For Net Profit / Share (Rs.), as of Mar 25, the value is -0.19. This value is below the healthy minimum of 2. It has decreased from 0.25 (Mar 24) to -0.19, marking a decrease of 0.44.
- For PBDIT Margin (%), as of Mar 25, the value is 3.40. This value is below the healthy minimum of 10. It has decreased from 5.23 (Mar 24) to 3.40, marking a decrease of 1.83.
- For PBIT Margin (%), as of Mar 25, the value is 0.66. This value is below the healthy minimum of 10. It has decreased from 3.85 (Mar 24) to 0.66, marking a decrease of 3.19.
- For PBT Margin (%), as of Mar 25, the value is -2.91. This value is below the healthy minimum of 10. It has decreased from 2.13 (Mar 24) to -2.91, marking a decrease of 5.04.
- For Net Profit Margin (%), as of Mar 25, the value is -2.85. This value is below the healthy minimum of 5. It has decreased from 1.59 (Mar 24) to -2.85, marking a decrease of 4.44.
- For Return on Networth / Equity (%), as of Mar 25, the value is -1.49. This value is below the healthy minimum of 15. It has decreased from 1.93 (Mar 24) to -1.49, marking a decrease of 3.42.
- For Return on Capital Employeed (%), as of Mar 25, the value is 0.25. This value is below the healthy minimum of 10. It has decreased from 3.45 (Mar 24) to 0.25, marking a decrease of 3.20.
- For Return On Assets (%), as of Mar 25, the value is -0.92. This value is below the healthy minimum of 5. It has decreased from 1.11 (Mar 24) to -0.92, marking a decrease of 2.03.
- For Long Term Debt / Equity (X), as of Mar 25, the value is 0.37. This value is within the healthy range. It has increased from 0.35 (Mar 24) to 0.37, marking an increase of 0.02.
- For Total Debt / Equity (X), as of Mar 25, the value is 0.51. This value is within the healthy range. It has increased from 0.48 (Mar 24) to 0.51, marking an increase of 0.03.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 0.31. It has decreased from 0.65 (Mar 24) to 0.31, marking a decrease of 0.34.
- For Current Ratio (X), as of Mar 25, the value is 6.51. This value exceeds the healthy maximum of 3. It has increased from 4.48 (Mar 24) to 6.51, marking an increase of 2.03.
- For Quick Ratio (X), as of Mar 25, the value is 5.35. This value exceeds the healthy maximum of 2. It has increased from 3.64 (Mar 24) to 5.35, marking an increase of 1.71.
- For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 20. There is no change compared to the previous period (Mar 24) which recorded 0.00.
- For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 20. There is no change compared to the previous period (Mar 24) which recorded 0.00.
- For Earning Retention Ratio (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 40. There is no change compared to the previous period (Mar 24) which recorded 0.00.
- For Cash Earning Retention Ratio (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 40. There is no change compared to the previous period (Mar 24) which recorded 0.00.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 0.94. This value is below the healthy minimum of 3. It has decreased from 3.05 (Mar 24) to 0.94, marking a decrease of 2.11.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 0.20. This value is below the healthy minimum of 3. It has decreased from 1.93 (Mar 24) to 0.20, marking a decrease of 1.73.
- For Enterprise Value (Cr.), as of Mar 25, the value is 12.03. It has decreased from 12.28 (Mar 24) to 12.03, marking a decrease of 0.25.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 1.75. This value is within the healthy range. It has increased from 0.75 (Mar 24) to 1.75, marking an increase of 1.00.
- For EV / EBITDA (X), as of Mar 25, the value is 51.31. This value exceeds the healthy maximum of 15. It has increased from 14.46 (Mar 24) to 51.31, marking an increase of 36.85.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 0.84. This value is below the healthy minimum of 1. It has increased from 0.39 (Mar 24) to 0.84, marking an increase of 0.45.
- For Retention Ratios (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 30. There is no change compared to the previous period (Mar 24) which recorded 0.00.
- For Price / BV (X), as of Mar 25, the value is 0.44. This value is below the healthy minimum of 1. It has decreased from 0.47 (Mar 24) to 0.44, marking a decrease of 0.03.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 0.84. This value is below the healthy minimum of 1. It has increased from 0.39 (Mar 24) to 0.84, marking an increase of 0.45.
- For EarningsYield, as of Mar 25, the value is -0.03. This value is below the healthy minimum of 5. It has decreased from 0.04 (Mar 24) to -0.03, marking a decrease of 0.07.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in CHD Chemicals Ltd:
- Net Profit Margin: -2.85%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 0.25% (Industry Average ROCE: 15.37%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: -1.49% (Industry Average ROE: 8.86%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 0.2
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 5.35
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 0 (Industry average Stock P/E: 86.71)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0.51
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: -2.85%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Trading & Distributors | SCF 214, Motor Market, Chandigarh Chandigarh 0 | Contact not found |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Ankit Kothari | Managing Director |
| Mr. Subhash Chander | Non Executive Director |
| Mr. Vijender Singh | Non Exe. & Ind. Director |
| Mr. Mahtab Singh | Non Exe. & Ind. Director |
| Mrs. Santosh Rani | Non Exe. & Ind. Director |
FAQ
What is the intrinsic value of CHD Chemicals Ltd?
CHD Chemicals Ltd's intrinsic value (as of 24 December 2025) is 2.37 which is 56.03% lower the current market price of 5.39, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's 5.45 Cr. market cap, FY2025-2026 high/low of 8.19/4.81, reserves of ₹2.80 Cr, and liabilities of 20.02 Cr.
What is the Market Cap of CHD Chemicals Ltd?
The Market Cap of CHD Chemicals Ltd is 5.45 Cr..
What is the current Stock Price of CHD Chemicals Ltd as on 24 December 2025?
The current stock price of CHD Chemicals Ltd as on 24 December 2025 is 5.39.
What is the High / Low of CHD Chemicals Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of CHD Chemicals Ltd stocks is 8.19/4.81.
What is the Stock P/E of CHD Chemicals Ltd?
The Stock P/E of CHD Chemicals Ltd is .
What is the Book Value of CHD Chemicals Ltd?
The Book Value of CHD Chemicals Ltd is 12.8.
What is the Dividend Yield of CHD Chemicals Ltd?
The Dividend Yield of CHD Chemicals Ltd is 0.00 %.
What is the ROCE of CHD Chemicals Ltd?
The ROCE of CHD Chemicals Ltd is 0.25 %.
What is the ROE of CHD Chemicals Ltd?
The ROE of CHD Chemicals Ltd is 1.51 %.
What is the Face Value of CHD Chemicals Ltd?
The Face Value of CHD Chemicals Ltd is 10.0.